Abvc Biopharma, Inc. (ABVC): Total Liabilities
$7.76M
As of 2025-12-31
$7.13M
As of 2026-06-30
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $7.76M | +13.9% | 2026-03-03, Balance as of period end |
| 2024-12-31 | $6.82M | +4.4% | 2026-03-03, Balance as of period end |
| 2023-12-31 | $6.53M | n/c | 2025-04-15, Balance as of period end |
| 2022-12-31 | $6.34M | n/c | 2024-03-13, Balance as of period end |
| 2021-12-31 | $4.83M | -46.0% | 2023-03-31, Balance as of period end |
| 2020-12-31 | $8.94M | +26.8% | 2022-03-31, Balance as of period end |
| 2019-12-31 | $7.05M | -37.5% | 2021-03-16, Balance as of period end |
| 2018-12-31 | $11.28M | n/c | 2020-05-15, Balance as of period end |
| 2017-12-31 | $4.40M | n/a | 2019-04-15, Balance as of period end |
| 2017-09-30 | $4.15M | -36.7% | 2018-01-16, Balance as of period end |
| 2016-09-30 | $6.56M | n/m | 2018-01-16, Balance as of period end |
| 2015-09-30 | $369.1K | +984.6% | 2017-09-22, Balance as of period end |
| 2014-09-30 | $34.0K | n/a | 2015-11-27, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Abvc Biopharma, Inc. (ABVC) | 2025-12-31 | $7.76M | +13.9% |
| Vyome Holdings, Inc (HIND) | 2025-12-31 | $2.74M | -52.6% |
| Allarity Therapeutics, Inc. (ALLR) | 2025-12-31 | $8.43M | -22.2% |
| Provectus Biopharmaceuticals, Inc. (PVCT) | 2025-12-31 | $7.00M | +0.4% |
| Regen BioPharma Inc (RGBP) | 2025-09-30 | $6.56M | +21.9% |
| Medicinova Inc (MNOV) | 2025-12-31 | $4.02M | +19.1% |
| Scienture Holdings, Inc. (SCNX) | 2025-12-31 | $14.06M | -45.5% |
| Clene Inc. (CLNN) | 2025-12-31 | $35.72M | -1.3% |
| Mereo BioPharma Group plc (MREO) | 2025-12-31 | $5.00M | -67.6% |
Compare ABVC, HIND, ALLR, PVCT side by side · Screen every company in Pharmaceutical Preparations ↗